Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 777-783

  Lefort, Agnès ^a,b   Panhard, Xavière ^c,d   Clermont, Olivier ^d   Woerther, Paul Louis ^c   Branger, Catherine ^d,e   Mentré, France ^c,d   Fantin, Bruno ^a,b   Wolff, Michel ^b,c   Denamur, Erick ^d  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d INSERM   (France)

^e HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NETILMICIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ADULT; AGED; AGING; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; ESCHERICHIA COLI INFECTION; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IREA GENE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SKIN; TOBACCO DEPENDENCE; URINARY TRACT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COHORT STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NICOTIANA TABACUM;

EID: 79952345934     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01902-10     Document Type: Article

References (54)

1. Alteri, C. J., E. C. Hagan, K. E. Sivick, S. N. Smith, and H. L. Mobley. 2009. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5:e1000586.
2. Biedenbach, D. J., G. J. Moet, and R. N. Jones. 2004. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn. Microbiol. Infect. Dis. 50:59-69.
3. Bingen, E., et al. 1998. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J. Infect. Dis. 177:642-650.
4. Bingen-Bidois, M., et al. 2002. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect. Immun. 70:3216-3226.
5. Campillo, B., J. P. Richardet, T. Kheo, and C. Dupeyron. 2002. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin. Infect. Dis. 35:1-10.
6. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
7. Conn, H. O. 1964. Spontaneous peritonitis and bacteremia in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome. Ann. Intern. Med. 60:568-580.
8. Cortes, M. A., et al. 2008. Inactivation of ibeA and ibeT results in decreased expression of type 1 fimbriae in extraintestinal pathogenic Escherichia coli strain BEN2908. Infect. Immun. 76:4129-4136.
9. Courpon-Claudinon, A., et al. 23 July 2010. Bacteremia due to third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin. Microbiol. Infect. [Epub ahead of print.] doi:10.1111/j.1469-0691.2010.03298.x.
10. Croxen, M. A., and B. B. Finlay. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26-38.
11. Diekema, D. J., et al. 2003. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J. Clin. Microbiol. 41:3655-3660.
12. Gordon, D. M., O. Clermont, H. Tolley, and E. Denamur. 2008. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ. Microbiol. 10:2484-2496.
13. Hacker, J., G. Blum-Oehler, I. Muhldorfer, and H. Tschape. 1997. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol. Microbiol. 23:1089-1097.
14. Hekker, T. A., et al. 2000. Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia. Eur. J. Clin. Microbiol. Infect. Dis. 19:312-316.
15. Heron, M. 2007. Deaths: leading causes for 2004. Natl. Vital Stat. Rep. 56:1-95.
16. Huang, S. H., et al. 2001. A novel genetic island of meningitic Escherichia coli K1 containing the ibeA invasion gene (GimA): functional annotation and carbon-source-regulated invasion of human brain microvascular endothelial cells. Funct. Integr. Genomics 1:312-322.
17. Jaureguy, F., et al. 2007. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin. Microbiol. Infect. 13:854-862.
18. Javaloyas, M., D. Garcia-Somoza, and F. Gudiol. 2002. Epidemiology and prognosis of bacteremia: a 10-y study in a community hospital. Scand. J. Infect. Dis. 34:436-441.
19. Johnson, J. R., et al. 2006. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J. Infect. Dis. 194:1141-1150.
20. Johnson, J. R., P. Delavari, M. Kuskowski, and A. L. Stell. 2001. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J. Infect. Dis. 183:78-88.
21. Johnson, J. R., and T. A. Russo. 2005. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int. J. Med. Microbiol. 295:383-404.
22. Kariyawasam, S., T. J. Johnson, and L. K. Nolan. 2006. The pap operon of avian pathogenic Escherichia coli strain O1:K1 is located on a novel pathogenicity island. Infect. Immun. 74:744-749.
23. Korhonen, T. K., R. Virkola, and H. Holthofer. 1986. Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect. Immun. 54:328-332.
24. Kurazono, H., et al. 2000. Characterization of a putative virulence island in the chromosome of uropathogenic Escherichia coli possessing a gene encoding a uropathogenic-specific protein. Microb. Pathog. 28:183-189.
25. Laupland, K. B., D. B. Gregson, D. L. Church, T. Ross, and J. D. Pitout. 2008. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin. Microbiol. Infect. 14:1041-1047.
26. Laupland, K. B., et al. 2007. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol. Infect. 135:1037-1042.
27. Lefort, A., et al. 2009. Predictive factors of the severity of Escherichia coli bacteremia: the Colibafi Study, abstr. K-260. Abstr. 49th Int. Conf. Antimicrob. Agents Chemother., San Francisco, CA.
28. Lyytikainen, O., et al. 2002. Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin. Infect. Dis. 35:e14-e19.
29. MacLean, D., J. D. Jones, and D. J. Studholme. 2009. Application of 'nextgeneration' sequencing technologies to microbial genetics. Nat. Rev. Microbiol. 7:287-296.
30. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-1554.
31. Martinez, J. A., et al. 2006. Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. J. Clin. Microbiol. 44:1468-1474.
32. Maslow, J. N., M. E. Mulligan, K. S. Adams, J. C. Justis, and R. D. Arbeit. 1993. Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. Clin. Infect. Dis. 17:89-97.
33. McCabe, W. R., B. Kaijser, S. Olling, M. Uwaydah, and L. A. Hanson. 1978. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J. Infect. Dis. 138:33-41.
34. O'Hanley, P., D. Lark, S. Falkow, and G. Schoolnik. 1985. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J. Clin. Invest. 75:347-360.
35. Petkovsek, Z., K. Elersic, M. Gubina, D. Zgur-Bertok, and M. S. Erjavec. 2009. Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J. Clin. Microbiol. 47:1811-1817.
36. Picard, B., et al. 1999. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67:546-553.
37. 2 of carboxylesterase B and host-dependent factors in Escherichia coli septicaemia. Epidemiol. Infect. 100:51-61.
38. Pittet, D., N. Li, R. F. Woolson, and R. P. Wenzel. 1997. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin. Infect. Dis. 24:1068-1078.
39. Restieri, C., G. Garriss, M. C. Locas, and C. M. Dozois. 2007. Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl. Environ. Microbiol. 73:1553-1562.
40. Russo, T. A., U. B. Carlino, and J. R. Johnson. 2001. Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli. Infect. Immun. 69:6209-6216.
41. Russo, T. A., and J. R. Johnson. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 5:449-456.
42. Russo, T. A., and J. R. Johnson. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754.
43. Schubert, S., A. Rakin, H. Karch, E. Carniel, and J. Heesemann. 1998. Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect. Immun. 66:480-485.
44. Schwaber, M. J., et al. 2006. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 50:1257-1262.
45. Skurnik, D., et al. 2005. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob. Agents Chemother. 49:3062-3065.
46. Srinivasan, U., B. Foxman, and C. F. Marrs. 2003. Identification of a gene encoding heat-resistant agglutinin in Escherichia coli as a putative virulence factor in urinary tract infection. J. Clin. Microbiol. 41:285-289.
47. Tenaillon, O., D. Skurnik, B. Picard, and E. Denamur. 2010. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 8:207-217.
48. Thulstrup, A. M., H. T. Sorensen, H. C. Schonheyder, J. K. Moller, and U. Tage-Jensen. 2000. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin. Infect. Dis. 31:1357-1361.
49. Touchon, M., et al. 2009. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet. 5:e1000344.
50. Uslan, D. Z., et al. 2007. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch. Intern. Med. 167:834-839.
51. Vazquez, F., M. C. Mendoza, G. Viejo, and F. J. Mendez. 1992. Survey of Escherichia coli septicemia over a six-year period. Eur. J. Clin. Microbiol. Infect. Dis. 11:110-117.
52. Weinstein, M. P., L. B. Reller, and J. R. Murphy. 1986. Clinical importance of polymicrobial bacteremia. Diagn. Microbiol. Infect. Dis. 5:185-196.
53. Wieser, A., et al. 2010. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect. Immun. 78:3432-3442.
54. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.